Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Adagene (ADAG) shares
Learn how to easily invest in Adagene shares.
Adagene is a biotechnology business based in the US. Adagene stocks (ADAG.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $13.61 – a decrease of 6.56% over the previous week. Adagene employs 198 staff and has a trailing 12-month revenue of around $1.8 million.
How to buy shares in Adagene
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ADAG – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Adagene stock price (NASDAQ:ADAG)Use our graph to track the performance of ADAG stocks over time.
Adagene shares at a glance
|Latest market close||$6.98|
|52-week range||$7.00 - $31.83|
|50-day moving average||$8.62|
|200-day moving average||$13.07|
|Wall St. target price||$31.64|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.50|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Adagene stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Adagene price performance over time
|1 week (2022-01-21)||-6.56%|
|1 month (2021-12-29)||-11.53%|
|3 months (2021-10-29)||-37.90%|
|6 months (2021-07-29)||-54.76%|
|1 year (2021-01-25)||N/A|
|2 years (2020-01-25)||N/A|
|3 years (2019-01-25)||N/A|
|5 years (2017-01-25)||N/A|
|Revenue TTM||$1.8 million|
|Gross profit TTM||$700,913|
|Return on assets TTM||-24.24%|
|Return on equity TTM||-45.09%|
|Market capitalisation||$310.3 million|
TTM: trailing 12 months
Adagene share dividends
We're not expecting Adagene to pay a dividend over the next 12 months.
Adagene Inc. , a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. Its lead product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase Ib clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a fully-human anti-CTLA-4 mAb for cancer treatment; and ADG116, a human ligand-blocking anti-CTLA-4 mAb, which is in Phase I clinical trial for the treatment of various tumors. The company was founded in 2011 and is headquartered in Suzhou, China. .
Adagene in the news
Adagene Announces First Patient Dosed with Novel, Proprietary Combination of Anti-CD137 Agonist, ADG106, and Anti-CTLA-4 Monoclonal Antibody, ADG116
Adagene : Announces First Patient Dosed with Novel, Proprietary Combination of Anti-CD137 Agonist, ADG106, and Anti-CTLA-4 Monoclonal Antibody, ADG116 - Form 6-K
Stocks That Hit 52-Week Lows On Tuesday
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.